Assay-dependent reclassification of biochemical hyperandrogenism in female androgen testing: CLIA versus LC-MS/MS under common clinical decision thresholds.

Zhang X, Xu H, Liu L, Yang L, Li R, Zhao R

Open source

DOI
10.1016/j.cca.2026.121347
Published
2026 Sep 16
Container
Clinica chimica acta; international journal of clinical chemistry
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.cca.2026.121347,
  title = {Assay-dependent reclassification of biochemical hyperandrogenism in female androgen testing: CLIA versus LC-MS/MS under common clinical decision thresholds.},
  author = {Zhang X and Xu H and Liu L and Yang L and Li R and Zhao R},
  year = {2026},
  journal = {Clinica chimica acta; international journal of clinical chemistry},
  doi = {10.1016/j.cca.2026.121347},
  url = {https://doi.org/10.1016/j.cca.2026.121347}
}

RIS

TY  - JOUR
TI  - Assay-dependent reclassification of biochemical hyperandrogenism in female androgen testing: CLIA versus LC-MS/MS under common clinical decision thresholds.
AU  - Zhang X
AU  - Xu H
AU  - Liu L
AU  - Yang L
AU  - Li R
AU  - Zhao R
PY  - 2026
JO  - Clinica chimica acta; international journal of clinical chemistry
DO  - 10.1016/j.cca.2026.121347
UR  - https://doi.org/10.1016/j.cca.2026.121347
ER  - 

APA

X, Z., H, X., L, L., L, Y., R, L., & R, Z. (2026). Assay-dependent reclassification of biochemical hyperandrogenism in female androgen testing: CLIA versus LC-MS/MS under common clinical decision thresholds.. Clinica chimica acta; international journal of clinical chemistry. https://doi.org/10.1016/j.cca.2026.121347

Source records